12/01/2018 22:15:00

True Leaf Announces Initial Closing of its Regulation A+ Offering

VERNON, British Columbia, Jan. 12, 2018 (GLOBE NEWSWIRE) -- True Leaf Medicine International Ltd. (“True Leaf” or the “Company”) (CSE:MJ) (FSE:TLA) (OTCQB:TRLFF), announces that it has conducted an initial closing of its previously announced Regulation A+ offering for gross proceeds in the amount of C$6.18 million for 8,883,590 shares.

True Leaf’s Regulation A+ offering was qualified by the Securities and Exchange Commission (SEC) on November 21, 2017, and allows the Company to sell up to 14,285,715 common shares at an offering price of $0.70 CAD per share in the United States.

Boustead Securities, LLC, working with its affiliate, FlashFunders™ (www.flashfunders.com), is the lead managing selling agent and bookrunner for the offering. CrowdfundX is the digital marketing agency of record.

About True Leaf

Founded in 2013, True Leaf has two main operating divisions: True Leaf Medicine Inc. and True Leaf Pet Inc. The Company’s goal is to provide federally-approved cannabis products that will be sold across Canada and the United States. True Leaf Medicine Inc. was launched in July 2013 to become a licensed producer of medicinal cannabis for the Canadian market. True Leaf Medicine Inc. has been given approval by Health Canada to build its grow facility and will be subject to a Health Canada security inspection upon completion to allow for the cultivation, manufacture, and distribution of cannabis products. Currently, True Leaf does not have a license to produce cannabis.

Established in 2015, True Leaf Pet Inc. markets hemp-focused products for the pet industry. The Company launched the True Hemp™ pet supplement line in Canada, the United States, and Europe, becoming one of the first hemp-based pet product lines to be marketed worldwide. True Hemp™ North American products are free of CBD and THC, making them the first federally legal products to be marketed in Canada and the United States.

SEC Legends

An offering statement regarding this offering has been filed with the SEC. The SEC has qualified that offering statement, which only means that we may make sales of the securities described by the offering statement. It does not mean that the SEC has approved, passed upon the merits, or passed upon the accuracy or completeness of the information in the offering statement. You may obtain a copy of the offering circular that is part of that offering statement from: HERE

Forward-Looking Statements

This news release contains forward-looking statements; and management may make additional forward-looking statements in response to your questions. Such written and oral disclosures are made pursuant to the Safe Harbor provision of the Private Securities Litigation Reform Act of 1995. Although we believe our expectations expressed in such forward-looking statements are reasonable, we cannot assure you that they will be realized. Investors are cautioned that such forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from the anticipated results, and therefore we refer you to a more detailed discussion of the risks and uncertainties in the Company’s filings with the Securities and Exchange Commission when available. The forward-looking statements contained in this news release are made only as of today; and True Leaf Medicine International Ltd. is under no obligation to revise or update these forward-looking statements.

Media Contact:                

Paul Sullivan                                                      

Director, Public Relations

Paul@trueleaf.com

O: 604-685-4742

M: 604-603-7358

Investor Contact:

Kevin Bottomley (Canada)

Director and Corporate Relations

Kevin@trueleaf.com

M: 778-389-9933

Tirth Patel (US)

Edison Advisors

tpatel@edisongroup.com  

O: 646-653-7035

Follow True Leaf

trueleaf.com

twitter.com/trueleafpet

facebook.com/trueleafmedicine

instagram.com/trueleafpet

Primary Logo

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
16 Oct
DANSKE
Jeg tror aldrig jeg har oplevet en person, der var så bitter som du er. Du bruger en ufattelig masse..
34
19 Oct
DANSKE
Borgen og Andersen sad i direktionsvognen, på vej hjem efter en lang dag hos bagmandspolitiet. Stemn..
33
15 Oct
DANSKE
Stop dog for helvede dine sindsyge indlæg. Det er brugere som dig der fuldkommen smadrer det her for..
31
14 Oct
DANSKE
En korruptionsbekæmper skudt i Moskva, er nu også blevet Danske Banks skyld, hvor ussel kan denne p..
18
18 Oct
I:DAX
Tjekkiets præsident Vaclav Klaus har et godt bud...   Europa er blevet svækket af den venstreoriente..
17
20 Oct
I:DAX
Matthew jeg har for sjov kigget lidt på resultaterne af dine kriterier for dødskryds. Det var mening..
15
19 Oct
VWS
Vestas wins 294 MW order in South African auction and introduces the first V136-4.2 MW turbines in A..
15
17 Oct
VELO
  Virker også fint her. Vil desuden lige sende en stor ros til alle jer debattør, for en god og sagl..
15
16 Oct
VELO
HVAD SIGER VELOXIS og HVAD GØR MARKEDET...    Lad os starte med hvad sagde Craig Collard ved regnska..
14
15 Oct
VELO
Hej Veloxis er i dag nævnt som en af de 3 aktier man bør fokusere på. https://play.borsen.dk/klip/5b..
14

HSBC Bank Plc : Form 8.5 (EPT/RI) - Lonmin PLC

22/02/2018 10:54:53
FORM 8.5 EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Name of exempt principal trader: HSBC BANK PLC (b) Name of offeror/offeree i..

Rathbone Brothers Plc : Preliminary announcement of 2017 results

22/02/2018 07:00:19
Funds under management up 14.3% to £39.1 billionThis is a preliminary statement of annual results published in accordance with FCA Listing Rule 9.7A. It covers the year ended 31 December 2017. Mark Nicholls, Chairman of Rathbone Brothers Plc, said: "UK and global investment markets performed well in 2017, with some indices reaching record levels towards the end of the year. This outcome has b..

Elliott Capital Advisors, L.P : Form 8.3 - GKN Plc

Related news
21/02/2018 15:25:10
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser: Elliott Capital Advisors, L.P. (for itself and related general partners ..

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
TESARO Announces Data Presentations at ESMO 2018 Congress
2
CORRECTION: Sage Intacct Customer RapidRatings Wins Ventana Research Office of Finance Digital Leadership Award
3
PHILIP MORRIS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Philip Morris International Inc. - PM
4
Pomerantz Law Firm Announces the Filing of a Class Action against Pretium Resources, Inc. and Certain Officers – PVG
5
UPDATE – GrandOmics Biosciences Offers Genetic Test Using the Saphyr System for Molecular Diagnosis of Facioscapulohumeral Muscular Dystrophy (FSHD) in China

Buy and sell signals

  • Trend
  • Moneymachine

Copyright Berlingske Media 2018  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
21 October 2018 01:08:32
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20181005.3 - EUROWEB5 - 2018-10-21 02:08:32 - 2018-10-21 01:08:32 - 1000 - Website: OKAY